Prognosis
Moderna Won’t Enforce Covid Vaccine Patents During Pandemic
- Company said it will offer licenses for post Covid-use
- Advocacy group says all vaccine developers should follow suit
This article is for subscribers only.
Moderna Inc. said it wouldn’t enforce its patents related to Covid-19 vaccines during the pandemic, in an effort to not deter other companies and researchers from making similar shots.
“While the pandemic continues, Moderna will not enforce our Covid-19 related patents against those making vaccines intended to combat the pandemic,” the company said in a statement on Thursday.